Latest News for: glp-1

Edit

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

Watauga Democrat 24 Feb 2026
... a new–generation cAMP–biased GLP–1 receptor agonist.
Edit

US Pen Needles Market to Reach $1.53 Billion by 2031 as Diabetes Prevalence and GLP-1 ...

GetNews 24 Feb 2026
Growth is being driven by the expanding insulin-dependent population, broader adoption of injectable GLP-1 therapies, and the continued shift toward patient-centric, home-based diabetes management.
Edit

News24 | Weight loss jabs skyrocket in SA: Can generics make GLP-1s affordable by 2027?

News24 23 Feb 2026
The high cost of patented GLP-1s and absence of generics remain a major impediment to access in SA, where the medicines are unavailable in the public sector and often unaffordable ... .
Edit

Fancy clothes, mealtime alarms and Disney princess gigs: How GLP-1s are changing people's lives in ...

CNBC 23 Feb 2026
GLP-1 drugs for weight loss are growing in popularity in the U.S. and across the world. Here's what some users say about their experiences with the medicines ... .
Edit

Microdosing Ozempic: The Low-Dose GLP-1 Trend Explained

TimesDaily 23 Feb 2026
GLP-1 receptor agonists are widely used in metabolic ...
Edit

SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development (SureNano Science Ltd)

Public Technologies 23 Feb 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 129650477) .
Edit

Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

Invezz 23 Feb 2026
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart ... Lilly’s bigger bet is that the next phase of the GLP-1 boom won’t be won purely on clinical results. GLP-1 drugs are ...
Edit

GLP-1 Drugs Are Disrupting the $1 Trillion U.S. Food Industry – Cape Crystal Brands Says ...

GetNews 23 Feb 2026
Summit, NJ, USA - February 23, 2026 - With GLP-1 medications like Ozempic, Wegovy, and Mounjaro now used by an estimated 15-20 million Americans — and projections suggesting that number could double within the decade, the U.S.
Edit

Why Eli Lilly is suddenly pulling ahead in the GLP-1 weight-loss race

Fast Company 23 Feb 2026
Per a press release , the KwikPen contains a months-worth of Zepbound, Eli Lilly’s GLP-1 designed to combat obesity, and it’s designed to make taking the medicine more convenient ... As GLP-1 usage ...
Edit

How Weight-Loss Drugs Are Changing People’s Relationship to Exercise

New York Times 23 Feb 2026
For some people, the medications have transformed their relationship with physical activity ... .
Edit

GLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies

Usatoday 22 Feb 2026
What to know about the side effects of GLP-1 drugs. With class action lawsuits filed, these are the alleged side effects of GLP-1 drugs, like Ozempic, Wegovy and Mounjaro ... The company still sells injectable GLP-1 medications.
Edit

'The View' cohosts discuss GLP-1s, weight loss. 'We all did it.'

Usatoday 21 Feb 2026
"In (Pritzker's) state, he expanded GLP-1 coverage for state employees with taxpayer dollars. So, you can't do that while not answering those tough questions about GLP-1s," Chrisley said during the Feb.
Edit

GLP-1 medications don’t work for everyone. A local doctor says surgery is still an option

Wtop 21 Feb 2026
She tried a GLP-1 drug, but a negative reaction sent her to the hospital ... “But not every patient responds to GLP-1s ... Obesity surgery rates have not changed since GLP-1 drugs, such as Ozempic and Mounjaro, arrived on the scene.
Edit

Buy this best-in-class GLP-1 leader as competition heats up, says Barclays

CNBC 20 Feb 2026
Barclays' $1,350 price target implies upside of 32% ... .
Edit

Novo Nordisk’s Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity

Nasdaq Globe Newswire 20 Feb 2026
.

Article Search

tools
×
×
×
×